Trade Centessa Pharmaceuticals Limited - CNTA CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.12
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.021485 %(-$0.43)Trade size with leverage ~ $2,000.00Money from leverage ~ $$1,000.00Go to platform: -0.02149%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.000738 %(-$0.01)Trade size with leverage ~ $2,000.00Money from leverage ~ $$1,000.00Go to platform: -0.00074%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.021485 %
  (-$0.43)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.000738 %
  (-$0.01)

Key Stats

• Prev. Close: 40.1
• Open: 39.99
• 1-Year Change: 221.98%
• Day's Range: 39.99 - 40.48

Trade Centessa Pharmaceuticals Limited - CNTA

Centessa Pharmaceuticals Limited (NASDAQ: CNTA) is a U.K.-based biotech company operating a unique decentralized R&D model across multiple subsidiaries targeting rare and specialty diseases. Its pipeline includes candidates in hematology, immunology, and oncology, with a focus on asset-centric development efficiency. Backed by life sciences investors, Centessa aims to streamline drug discovery while de-risking capital deployment. It offers investors a diversified, early-stage biotech platform with program-level optionality and clinical momentum.